These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 31012122

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. p53 protein and proliferating cell nuclear antigen in eccrine poroma and porocarcinoma. an immunohistochemical study.
    Tateyama H, Eimoto T, Tada T, Inagaki H, Nakamura T, Yamauchi R.
    Am J Dermatopathol; 1995 Oct; 17(5):457-64. PubMed ID: 8599450
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas.
    Bai M, Vlachonikolis J, Agnantis NJ, Tsanou E, Dimou S, Nicolaides C, Stefanaki S, Pavlidis N, Kanavaros P.
    Mod Pathol; 2001 Nov; 14(11):1105-13. PubMed ID: 11706071
    [Abstract] [Full Text] [Related]

  • 9. P53 protein expression in eccrine poroma and porocarcinoma.
    Akalin T, Sen S, Yücetürk A, Kandiloğlu G.
    Am J Dermatopathol; 2001 Oct; 23(5):402-6. PubMed ID: 11801771
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations.
    Harms PW, Hovelson DH, Cani AK, Omata K, Haller MJ, Wang ML, Arps D, Patel RM, Fullen DR, Wang M, Siddiqui J, Andea A, Tomlins SA.
    Hum Pathol; 2016 May; 51():25-31. PubMed ID: 27067779
    [Abstract] [Full Text] [Related]

  • 12. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
    Geradts J, Fong KM, Zimmerman PV, Maynard R, Minna JD.
    Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Spindle cell porocarcinoma with a novel YAP1::MAML3 fusion.
    Li P, Busam KJ.
    J Cutan Pathol; 2024 Mar; 51(3):226-229. PubMed ID: 38088454
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An Unusual Case of a Scrotal Porocarcinoma and Review of the Literature.
    Hartsough EM, Moran J, Devins K, Wszolek M, Cornejo KM.
    Am J Dermatopathol; 2023 Jan 01; 45(1):51-55. PubMed ID: 36484607
    [Abstract] [Full Text] [Related]

  • 20. Eccrine poroma and porocarcinoma on the same unusual location: report on two cases.
    Ma H, Liao M, Qiu S, Lu R, Lu C.
    An Bras Dermatol; 2015 Jan 01; 90(3 Suppl 1):69-72. PubMed ID: 26312678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.